- Report
- September 2024
- 296 Pages
Global
From €4013EUR$4,197USD£3,359GBP
- Report
- March 2025
- 194 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Book
- April 2013
- 320 Pages
The Perinatal Stem Cell market is a subset of the larger Stem Cell market. Perinatal stem cells are derived from umbilical cord blood and tissue, and are used in regenerative medicine and cell therapy. These cells are multipotent, meaning they can differentiate into a variety of cell types, and are believed to have anti-inflammatory and immunomodulatory properties. Perinatal stem cells are used to treat a variety of conditions, including neurological disorders, cardiovascular diseases, and autoimmune diseases.
The Perinatal Stem Cell market is growing rapidly, driven by increasing demand for stem cell therapies and the development of new technologies. Companies in this market are focused on developing and commercializing products and services related to perinatal stem cells, such as cell processing, storage, and banking. Examples of companies in this market include Cryo-Cell International, Cord Blood Registry, and StemCyte. Show Less Read more